ºÒÀÓ Ä¡·á ¼ºñ½º ½ÃÀåÀº 2030³â±îÁö 1,242¾ï ´Þ·¯¿¡ µµ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.
2023³â¿¡ 470¾ï ´Þ·¯·Î ÃßÁ¤µÈ ºÒÀÓ Ä¡·á ¼ºñ½º ½ÃÀåÀº 2030³â¿¡´Â 1,242¾ï ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº 14.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½Å¼±ºñµµ³Ê ¼ºñ½º´Â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 16.1%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã¿¡´Â 753¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³Ãµ¿ ºñ°ø¿© ¼ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 13.7%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 121¾ï ´Þ·¯, Áß±¹Àº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 19.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¹Ì±¹ÀÇ ºÒÀÓ Ä¡·á ¼ºñ½º ½ÃÀåÀº 2023³â 121¾ï ´Þ·¯·Î ÃßÁ¤µÆ½À´Ï´Ù. ¼¼°èÀÇ 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 317¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº 19.3%ÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº °¢°¢ 10.2%¿Í 12.6%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 11.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ ºÒÀÓ Ä¡·á ¼ºñ½º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ ¿ä¾à
ºÒÀÓ Ä¡·á ¼ºñ½º´Â Àç»ý»ê °Ç°°ú °¡Á· °èȹ¿¡ ¾î¶² Çõ¸íÀ» °¡Á®¿Ô´Â°¡?
ºÒÀÓ Ä¡·á ¼ºñ½º´Â ÀÓ½ÅÀÇ °úÁ¦¿¡ Á÷¸éÇÏ´Â °³Àΰú Ä¿Çÿ¡°Ô °í±Þ ÀÇ·á °³ÀÔ°ú °³º° Äɾ Á¦°øÇÔÀ¸·Î½á »ý½Ä ÀÇ·á ¹× °¡Á· °èȹÀ» º¯È½Ã۰í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Àνİú ¼ö¿ëÀÌ ³ô¾ÆÁö´Â °¡¿îµ¥ ü¿Ü¼öÁ¤(IVF), ³ÀÚ µ¿°á, À¯ÀüÀÚ ½ºÅ©¸®´× µî º¸Á¶»ý½Ä±â¼ú ±â¼ú(ART)ÀÇ Áøº¸´Â ¼¼°èÀÇ ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µé¿¡°Ô Èñ¸ÁÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á ¼ºñ½º¿¡´Â ºÒÀÓÀÇ Áø´Ü ¹× Ä¡·á, °¡Á· °èȹ Áö¿ø, »ý½Ä ±â´É °³¼± µî¿¡ µµ¿òÀÌ µÇ´Â ´Ù¾çÇÑ Ä¡·á°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼ºñ½º´Â Çö´ë °Ç° °ü¸®¿¡¼ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ°í ÀÖÀ¸¸ç, ³ªÀÌ¿Í º´¸®, ±âŸ ¿äÀο¡µµ ºÒ±¸ÇÏ°í °³Àΰú ºÎºÎ°¡ ºÎ¸ð°¡ µÇ´Â ²ÞÀ» ½ÇÇöÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÃÖ±Ù Ãâ»ê Áö¿¬, ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È, ºÒÀÓ·ü »ó½Â µîÀÇ »çȸÀû º¯È·Î ÀÎÇØ ºÒÀÓ Ä¡·á ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á Àü¹® Ŭ¸®´ÐÀº ºÒÀÓ ÆÇÁ¤°ú È£¸£¸ó Ä¡·áºÎÅÍ ÃÖ÷´Ü ART Ä¡·á±îÁö ´Ù¾çÇÑ ¼ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ¹Ì·¡ÀÇ ÀÓ½ÅÀ» À§ÇØ »ý½Ä ´É·ÂÀ» À¯ÁöÇϰíÀÚÇÏ´Â ¿©¼ºµé »çÀÌ¿¡¼ ³ÀÚ µ¿°á Áõ°¡°¡ Å« µ¿ÇâÀ̵Ǿú½À´Ï´Ù. ÀÌ·¯ÇÑ ºÒÀÓ Ä¡·á ¼ºñ½ºÀÇ È®´ë´Â °³ÀÎÀÌ »ý½Ä¿¡ ´ëÇÑ °Ç°À» ÅëÁ¦ÇÏ´Â ÈûÀ» ÁÙ»Ó¸¸ ¾Æ´Ï¶ó, ƯÈ÷ µ¿¼º Ä¿ÇÃÀ̳ª ÆíºÎ¸ð, »ý½Ä¿¡ °üÇÑ °Ç° °úÁ¦¿¡ Á÷¸éÇϰíÀÖ´Â »ç¶÷µé¿¡°Ô °¡Á· °èȹÀ»º¸´Ù Ä£¼÷ÇÏ°í Æ÷°ý Çϰí ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á°¡ ÁøÀüµÇ°í »çȸÀûÀ¸·Î ¹Þ¾Æµé¿©Áö¸é¼ ÀÌ·¯ÇÑ ¼ºñ½º´Â »ç¶÷µéÀÌ °¡Á· °èȹÀ» ¼¼¿ì´Â ¹æ¹ý¿¡ ÀÖ¾î¼ Çõ½ÅÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù.
¿Ö ºÒÀÓ Ä¡·á ¼ºñ½º´Â »ý½Ä ¹®Á¦¸¦ ÇØ°áÇÏ°í °¡Á· °èȹ ¿É¼ÇÀ» ³ÐÈ÷´Â µ¥ Áß¿äÇմϱî?
ºÒÀÓ Ä¡·á ¼ºñ½º´Â ÀÚ¿¬ ÀӽŠÀå¾Ö¿¡ Á÷¸éÇÏ´Â °³Àΰú ºÎºÎ¿¡°Ô ÀÇÇÐÀû ÇØ°áÃ¥À» Á¦°øÇϱ⠶§¹®¿¡ »ý½Ä ¹®Á¦¸¦ ÇØ°áÇÏ°í °¡Á· °èȹ ¿É¼ÇÀ» ³ÐÈ÷´Â µ¥ Áß¿äÇÕ´Ï´Ù. ¼¼°èÀÇÀûÀ¸·Î ¾à 10-15%ÀÇ Ä¿Çÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ´Â ºÒÀÓÁõÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ´Â °¡¿îµ¥ ºÒÀÓÄ¡·á ¼ºñ½º´Â ÀÓ½ÅÀ» ¹æÇØÇÏ´Â ±âÃÊ ÁúȯÀ» Áø´Ü,Ä¡·áÇÔÀ¸·Î½á Èñ¸Á°ú Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. ¿¬·É, È£¸£¸ó ±ÕÇüÀÇ È¥¶õ, À¯ÀüÀû ¿äÀÎ, »ýȰ ½À°ü ¹®Á¦ µî ºÒÀÓÀº Á¤½ÅÀûÀ¸·Î³ª À°Ã¼ÀûÀ¸·Î ºÎ´ãÀÌ µÇ´Â °ÍÀÔ´Ï´Ù. ü¿Ü¼öÁ¤(IVF), Àڱà ³» Àΰø¼öÁ¤(IUI), ³ÀÚ¿Í Á¤ÀÚÀÇ Á¦°ø°ú °°Àº ºÒÀÓ Ä¡·á´Â ÀÌ·¯ÇÑ Àå¾Ö¸¦ ±Øº¹Çϰí ÀÓ½ÅÀ» ¼º°ø½Ãų ¼ö ÀÖ½À´Ï´Ù.
ºÒÀÓ Ä¡·á ¼ºñ½º´Â ¶ÇÇÑ ºÒÀÓ¿¡ Á÷¸éÇÏÁö ¾Ê´õ¶óµµ °¡Á· °èȹÀ» À§ÇÑ ´ë¾ÈÀ» ã´Â »ç¶÷µé¿¡°Ô ¼±ÅñÇÀ» Á¦°øÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °³ÀÎÀûÀÎ ÀÌÀ¯³ª °æ·Â»óÀÇ ÀÌÀ¯·Î Ãâ»êÀ» ´ÊÃß±â·Î ¼±ÅÃÇÑ ¿©¼ºÀº ³ÀÚ µ¿°á¿¡ ÀÇÁ¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÒÀÓ Ä¡·á ¼ºñ½º´Â LGBTQÀÇ °³Àΰú Ä¿ÇÃ, °¡Á·À» ¸¸µé±â À§ÇØ ³ÀÚ Á¦°ø, Á¤ÀÚ Á¦°ø, ´ë¸® Ãâ»êÀ» ÇÊ¿ä·ÎÇÏ´Â ÇÑ ºÎ¸ð¿¡°Ôµµ Áß¿äÇÑ ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ºñ½º´Â ºÎ¸ð°¡ µÇ´Â °ÍÀÌ »ý¹°ÇÐÀû Á¦¾àÀ̳ª ÀüÅëÀûÀÎ °¡Á· ±¸¼º¿¡ ÀÇÇØ Á¦ÇѵÇÁö ¾ÊÀ½À» º¸ÀåÇϸç, ¾î¸°À̸¦ °®±â À§ÇÑ º¸´Ù Á¾ÇÕÀûÀÌ°í ´Ù¾çÇÑ ±æÀ» Á¦°øÇÕ´Ï´Ù.
ºÒÀÓ Ä¡·á ¼ºñ½ºÀÇ ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿ªÇÒÀº ´Ù³¶¼º ³¼Ò ÁõÈıº(PCOS), Àڱà ³»¸·Áõ, Á¤ÀÚ ¼ö ¹× ¿îµ¿·ü °¨¼Ò¿Í °°Àº ³²¼º ºÒÀÓÁõ°ú °°Àº ÀÇÇÐÀû Áõ»ó¿¡ ´ëÇÑ ´ëÀÀÀÔ´Ï´Ù. ºÒÀÓÄ¡·á Ŭ¸®´Ð¿¡¼´Â Àӽа¡´É¼ºÀ» ³ôÀ̱â À§ÇÑ Ä¡·á³ª °³ÀÔÀ» ½Ç½ÃÇß½À´Ï´Ù. °Ô´Ù°¡, À¯ÀüÀÚ ½ºÅ©¸®´×°ú Âø»ó Àü À¯ÀüÇÐÀû °Ë»ç(PGT)ÀÇ Áøº¸´Â ÀӽŠÀü¿¡ À¯ÀüÀÚ ÁúȯÀ» È®ÀÎÇÒ ¼ö ÀÖ°Ô Çϰí, ºÎ¸ð¿Í ¾Æ±â ¸ðµÎ¿¡°Ô °Ç°ÇÑ °á°ú¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù¹ýÀº ´õ ¸¹Àº »ç¶÷µéÀÌ º¹ÀâÇÑ »ý½Ä ¹®Á¦¸¦ ±Øº¹Çϰí ÀÌÀü¿¡´Â ºÒ°¡´ÉÇß´ø ¹æ½ÄÀ¸·Î °¡Á· Çü¼º ¿É¼ÇÀ» ³ÐÈ÷´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.
¸®ÇÁ·Î´öƼºê Çコ¿¡¼ ºÒÀÓ Ä¡·á ¼ºñ½ºÀÇ È®´ëÇÏ´Â ÀÀ¿ë°ú Çõ½ÅÀ̶õ?
ºÒÀÓ Ä¡·á ¼ºñ½ºÀÇ ÀÀ¿ë°ú Çõ½ÅÀº ÀÇ·á ±â¼ú, À¯ÀüÇÐ ¹× °³ÀÎÈµÈ »ý½Ä ÀÇ·áÀÇ ºñ¾àÀûÀÎ Áøº¸·Î ±Þ¼ÓÈ÷ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á ¼ºñ½º¿¡¼ °¡Àå Áß¿äÇÑ Áøº¸ Áß Çϳª´Â ü¿Ü¼öÁ¤(IVF)ÀÇ »ó½ÂÀÔ´Ï´Ù. ü¿Ü¼öÁ¤(IVF)Àº ü¿Ü¿¡¼ ³ÀÚ¸¦ ¼öÁ¤ÇÏ°í ¼öÁ¤¶õÀ» Àڱÿ¡ À̽ÄÇÏ´Â ¹æ¹ýÀÔ´Ï´Ù. ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ü¿Ü¼öÁ¤(IVF)ÀÇ ¼º°ø·üÀº Áõ°¡ÇÏ°í ºÒÀÓÀÇ °¡Àå È¿°úÀûÀÎ Ä¡·á¹ý Áß Çϳª°¡µÇ¾ú½À´Ï´Ù. Timelapse À̹ÌÁö ¹× ¹è¾Æ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú °°Àº ±â¼ú Çõ½ÅÀ¸·Î ¹è¾Æ ¹è¾ç»ç´Â ¹è¾Æ ¹ß´ÞÀ» º¸´Ù Á¤È®ÇÏ°Ô Æò°¡ÇÒ ¼ö ÀÖ¾î Âø»ó°ú Àӽмº°ø È®·üÀÌ Çâ»óµÇ¾ú½À´Ï´Ù.
³ÀÚ¿Í Á¤ÀÚÀÇ µ¿°á±â¼úµµ ´ëÆø °³¼±µÇ¾î ÀÓÈ¿¼º ¿ÂÁ¸ÀÇ ±âȸ°¡ ´Ã¾î³µ½À´Ï´Ù. À¯¸®È¸¦ Æ÷ÇÔÇÑ µ¿°áº¸Á¸¹ýÀ» ÅëÇØ º¸´Ù ³ôÀº »ýÁ¸À²·Î ³ÀÚ¿Í Á¤ÀÚ¸¦ µ¿°áÇÒ ¼ö ÀÖ¾î ºÎ¸ð°¡ µÇ´Â ½Ã±â¸¦ ´ÊÃß´Â À¯¿¬¼ºÀ» °³Àο¡°Ô Á¦°øÇÕ´Ï´Ù. À̰ÍÀº ÈÇпä¹ý¿¡ ÀÇÇØ ÀӽżºÀ» ÀÒÀ» °¡´É¼ºÀÌ ÀÖ´Â ¾Ï ȯÀÚ³ª °³ÀÎÀû ¶Ç´Â ¾÷¹«»óÀÇ ÀÌÀ¯·Î ÀÓÈ¿¼ºÀ» ¿ÂÁ¸ÇÏ°í ½ÍÀº ¿©¼º¿¡°Ô ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ Á¤ÀÚ ÃßÃâ ±â¼úÀÇ Áøº¸·Î Á¤ÀÚ ¼ö°¡ ÀûÀº ³²¼º°ú ´Ù¸¥ »ý½Ä ´É·Â¿¡ ¹®Á¦°¡ÀÖ´Â ³²¼ºµµ º¸Á¶»ý½Ä±â¼ú ±â¼ú¿¡ ÀÇÇÑ ÀÓ½ÅÀ» °¡´ÉÇϰÔÇÏ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.
ºÒÀÓ Ä¡·á ¼ºñ½ºÀÇ ¶Ç ´Ù¸¥ Çõ½ÅÀûÀÎ Çõ½ÅÀº Âø»ó Àü ¹è¾ÆÀÇ À¯ÀüÀÚ ½ºÅ©¸®´×À» °¡´ÉÇÏ°Ô ÇÏ´Â Âø»ó Àü À¯ÀüÇÐÀû °Ë»ç(PGT)ÀÔ´Ï´Ù. PGT´Â Àڱà Ãà³óÁõ, °â»ó ÀûÇ÷±¸ ºóÇ÷, ÇåÆÃÅϺ´ µîÀÇ ¿°»öü ÀÌ»óÀ̳ª À¯Àü¼º ÁúȯÀ» °ËÃâÇÒ ¼ö ÀÖ¾î, ü¿Ü¼öÁ¤(IVF)½Ã¿¡ °Ç°ÇÑ ¹è¾Æ¸¸ÀÌ À̽ĵǴ °ÍÀ» º¸ÁõÇÕ´Ï´Ù. ÀÌ ±â¼úÀº Àӽмº°øÀÇ °¡´É¼ºÀ» ³ôÀϻӸ¸ ¾Æ´Ï¶ó À¯»ê°ú ¾î¸°ÀÌÀÇ À¯Àü ÁúȯÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. À¯Àü »ó´ãÀº ÇöÀç ºÒÀÓ Ä¡·á ¼ºñ½º¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀ̸ç, Ä¿ÇÃÀº À¯ÀüÀû üÁú¿¡ µû¶ó »ý½Ä ¼±Åÿ¡ ´ëÇÑ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ¿¡ °áÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸ ¿Ü¿¡µµ ºÒÀÓ Ä¡·á ¼ºñ½º´Â »ý½Ä ÀÇ·á¿¡ ´ëÇѺ¸´Ù Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀ¸·Î È®´ëµÉ Àü¸ÁÀ̰í ÀÖ½À´Ï´Ù. Ŭ¸®´ÐÀº ºÒÀÓ Ä¡·áÀÇ °¨Á¤Àû, ½ÅüÀû, ½É¸®Àû Ãø¸éÀ» ´Ù·ç´Â °ÍÀÇ Á߿伺À» ÀνÄÇÏ°í ºÒÀÓ Ä¡·á ÄÚĪ, ¿µ¾ç Áöµµ, Á¤½Å °Ç° »ó´ã, ħ¼ú°ú °°Àº Áö¿ø ¼ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ºÒÀÓ Ä¡·á Ŭ¸®´ÐÀº ¶ÇÇÑ ¿ø°Ý ÀÇ·á »ó´ã, ºÒÀÓ Ä¡·á ÃßÀû ¾Û, ¿ø°Ý ¸ð´ÏÅ͸µÀÌ ³Î¸® »ç¿ëµÇ´Â µî µðÁöÅÐ °Ç° µµ±¸¸¦ ÅëÇÕÇÕ´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ Áß½ÉÀÇ Ä¡·á·ÎÀÇ ÀüȯÀº º¹ÀâÇÑ ºÒÀÓ Ä¡·á ¿©ÇàÀ» ´õ Å« Áö¿ø°ú ÆíÀǼºÀ¸·Î Ž»öÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.
ºÒÀÓ Ä¡·á ¼ºñ½ºÀÇ Çõ½ÅÀÇ ¶Ç ´Ù¸¥ ºÐ¾ß´Â ºÒÀÓ Ä¡·á¿¡¼ ÀΰøÁö´É(AI) ¹× ¸Ó½Å·¯´×ÀÇ »ç¿ëÀÇ È®´ëÀÔ´Ï´Ù. ÀΰøÁö´ÉÀÌÀÖ´Â ½Ã½ºÅÛÀº ȯÀÚ Á¤º¸, ¹è¾Æ ¹ß´Þ, Ä¡·á °á°ú µî°ú °°Àº ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµÇ¸ç Àǻ簡 ºÒÀÓ Ä¡·á °èȹ¿¡ ´ëÇѺ¸´Ù Á¤È®ÇÑ ÆÇ´ÜÀ» ³»¸®´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î, ÀΰøÁö´ÉÀº ȯÀÚÀÇ º´·Â, À¯ÀüÇÐ ¹× ¹è¾ÆÀÇ ÁúÀ» ±â¹ÝÀ¸·Î ü¿Ü¼öÁ¤(IVF)ÁÖ±âÀÇ ¼º°ø·üÀ» ¿¹ÃøÇÏ´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖÀ¸¸çº¸´Ù °³ÀÎȵǰí È¿°úÀûÀÎ Ä¡·á Àü·«À» °¡´ÉÇϰÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ºÒÀÓ Ä¡·á°¡ ´õ È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽±°í ¼º°øÇϱ⠽±°í °¡Á¤À» ±¸ÃàÇÏ·Á´Â °³Àΰú Ä¿Çÿ¡°Ô »õ·Î¿î °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù.
ºÒÀÓ Ä¡·á ¼ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ̶õ?
ºÒÀÓ Ä¡·á ¼ºñ½º ½ÃÀåÀÇ ¼ºÀå¿¡´Â ºÒÀÓÀÇ À¯º´·ü Áõ°¡, Ãâ»ê Áö¿¬, »ý½Ä ±â¼úÀÇ Áøº¸, ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ »çȸÀû ¼ö¿ë Áõ°¡ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ¼¼°èÀÇ ºÒÀÓ Áõ°¡À̸ç, ÀÌ´Â ³²³à ¸ðµÎ¿¡°Ô ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È, ȯ°æ ¿À¿° ¹°Áú, ½ºÆ®·¹½º, ºñ¸¸ ¹× ´Ù³¶¼º ³¼Ò ÁõÈıº(PCOS)°ú °°Àº º´¸®Çаú °°Àº ¿äÀÎÀº ºÒÀÓ·ü »ó½Â¿¡ ±â¿©ÇÕ´Ï´Ù. ÀÚ¿¬ÀÓ½ÅÀÇ ¾î·Á¿ò¿¡ Á÷¸éÇÏ´Â »ç¶÷ÀÌ ´Ã¾î³²¿¡ µû¶ó ü¿Ü¼öÁ¤, IUI, ÀÓÈ¿¼º ¿ÂÁ¸ µîÀÇ Ä¡·á°¡ ÀϹÝÀûÀ¸·Î µÇ¾î ºÒÀÓÄ¡·á ¼ºñ½º ¼ö¿ä´Â Áõ°¡ÀÇ ±æÀ» µû¶ó°¡°í ÀÖ½À´Ï´Ù.
ºÒÀÓ Ä¡·á ¼ºñ½º ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿ä¼Ò´Â Ãâ»ê Áö¿¬ÀÇ Ãß¼¼ÀÔ´Ï´Ù. °æ·Â, ±³À° ¹× °³ÀÎ ¸ñÇ¥¸¦ ¼±È£ÇÏ´Â ¿©¼ºÀÌ ´Ã¾î³ª´Â °¡¿îµ¥ ¸¹Àº ¿©¼ºµéÀÌ »îÀÇ ÈĹݿ¡ Àڳฦ °®±â·Î °áÁ¤Çß½À´Ï´Ù. ±×·¯³ª ƯÈ÷ ¿©¼º¿¡°Ô´Â ¿¬·É°ú ÇÔ²² »ý½Ä ´É·ÂÀÌ ÀúÇϵDZ⠶§¹®¿¡ ¿¬·ÉÀÌ ºÒÀÓÀÇ Áß´ëÇÑ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ³ÀÚ µ¿°á°ú ü¿Ü¼öÁ¤(IVF)À» Æ÷ÇÔÇÑ ºÒÀÓ Ä¡·á ¼ºñ½º´Â »ý½Ä ´É·ÂÀ» À¯ÁöÇÏ°í »îÀÇ ÈĹݺο¡ ÀÓ½ÅÇϱ⸦ ¿øÇÏ´Â ¿©¼º¿¡°Ô ¼Ö·ç¼ÇÀ» Á¦°øÇϸç ÀÌ·¯ÇÑ ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁý´Ï´Ù. °Ô´Ù°¡, ÀçÈ¥°ú È¥ÇÕ °¡Á· Áõ°¡¿¡ µû¶ó, ºÒÀÓ Ä¡·á ¼ºñ½º´Â ³ëÀÎ °³Àΰú ÇÔ²² ¾ÆÀ̸¦ °®°í ½Í¾îÇÏ´Â ºÎºÎ¿¡ ÀÌ¿ëµÇ°í ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
»ý½Ä±â¼úÀÇ Áøº¸µµ ºÒÀÓÄ¡·á ¼ºñ½º ½ÃÀå È®´ë¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Âø»ó Àü À¯Àü ÇÐÀû °Ë»ç(PGT), ŸÀÓ ·¦½º ¹è¾Æ À̹Ì¡, µ¿°áº¸Á¸ ±â¼ú µîÀÇ Çõ½ÅÀûÀÎ Ä¡·á·Î ºÒÀÓ Ä¡·áÀÇ ¼º°ø·üÀÌ Çâ»óµÇ¾î »ý½Ä º¸Á¶¸¦ ¿ä±¸ÇÏ´Â °³Àΰú Ä¿Çÿ¡°Ô ´õ¿í ¸Å·ÂÀûÀ̵Ǿú½À´Ï´Ù. ºÒÀÓ Ä¡·á Ŭ¸®´Ð¿¡¼ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº º¸´Ù ¸ÂÃã Ä¡·á¸¦ Á¦°øÇϰí Ä¡·á Àü·«À» ÃÖÀûÈÇÔÀ¸·Î½á Ä¡·á °á°ú¸¦ ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÇ Áøº¸´Â ºÒÀÓ Ä¡·á¸¦ ´õ È¿°úÀûÀ̰í Ä£¼÷ÇÏ°Ô ¸¸µé°í ´õ ¸¹Àº »ç¶÷µéÀÌ ºÒÀÓ Ä¡·á ¿É¼ÇÀ» ¸ð»öÇϵµ·Ï Ã˱¸ÇÕ´Ï´Ù.
ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ »çȸÀû ¼ö¿ë Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. °ú°Å¿¡´Â ±Ý±â½ÃµÇ¾î ¿À¸íÀ» ÀÔÇô ÀÖ´ø ºÒÀÓÄ¡·áµµ ÇöÀç´Â ƯÈ÷ ¼±Áø±¹¿¡¼ ³Î¸® ¹Þ¾Æµé¿©Áö°í ¹Þ¾Æµé¿©Áö°í ÀÖ½À´Ï´Ù. °øÀΰú À¯¸íÀÎÀÌ ºÒÀÓ Ä¡·á¿¡ ´ëÇØ °³¹æÀûÀ¸·Î ¸»ÇÔÀ¸·Î½á ºÒÀÓ¿¡ ´ëÇÑ Æí°ßÀÌ Èñ¹ÌÇØÁö°í, ´õ ¸¹Àº »ç¶÷µéÀÌ ºÒÀÓ Ä¡·á¸¦ ¹Þ°Ô µÇ¾î ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¿¼º °áÈ¥ ½ÂÀÎ, ´ë¸® Ãâ»ê ¹× ±âÁõÀÚ ÇÁ·Î±×·¥ÀÇ °¡¿ë¼º µî ¹ýÀû ¹× »çȸÀû Áøº¸´Â LGBTQÀÇ °³Àΰú ÇÑ ºÎ¸ð°¡ °¡Á·À» ±¸ÃàÇÒ ¼ö ÀÖ´Â »õ·Î¿î ±æÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á°¡ ´õ °¡±î¿öÁö°í Á¤»óȵʿ¡ µû¶ó ºÒÀÓ Ä¡·á ¼ºñ½º ½ÃÀåÀº °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù.
ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Á¤ºÎ Áö¿ø°ú °Ç° °ü¸® Àû¿ë È®´ëµµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ±¹°¡¿¡¼ º¸Çèȸ»ç¿Í °Ç° °ü¸® ½Ã½ºÅÛÀº ü¿Ü¼öÁ¤(IVF)°ú °°Àº ºÒÀÓ Ä¡·á¿Í °ü·ÃµÈ ºñ¿ëÀÇ ÀϺθ¦ ºÎ´ãÇϱ⠽ÃÀÛÇϰí ÀÖÀ¸¸ç, ´õ ¸¹Àº »ç¶÷µé¿¡°Ô ´õ ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸®ÇÁ·Î´öƼºê Çコ¸¦ ÃßÁøÇÏ°í ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ °æÁ¦Àû Áö¿øÀ» Á¦°øÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêµµ ÀÌ·¯ÇÑ ¼ºñ½º¿¡ ´ëÇÑ ¾×¼¼½º¸¦ ´Ã¸®´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. Ãâ»ý·üÀÌ ¶³¾îÁö´Â Áö¿ª¿¡¼´Â Á¤ºÎ°¡ Àα¸ Áõ°¡¸¦ ÃËÁøÇÏ´Â ±¹°¡Àû ³ë·ÂÀÇ ÀÏȯÀ¸·Î ºÒÀÓ Ä¡·á¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.
°á·ÐÀûÀ¸·Î ºÒÀÓÁõÀ» ±Øº¹Çϰųª ºÎ¸ð°¡ µÇ´Â ½Ã±â¸¦ ´ÊÃ߰ųª ºñÀüÅëÀûÀÎ °¡Á·Çü¼ºÀÇ ¼±ÅÃÀ» Ãß±¸Çϱâ À§ÇØ »ý½Äº¸Á¶ÀǷḦ ¿ä±¸ÇÏ´Â °³Àΰú Ä¿ÇÃÀÌ ´Ã¾î³²¿¡ µû¶ó ºÒÀÓÄ¡·á ¼ºñ½º ½ÃÀåÀº Å©°Ô ¼ºÀåÇϴ ż¼¸¦ Á¤µ·Çϰí ÀÖ½À´Ï´Ù. »ý½Ä±â¼úÀÇ Áøº¸, »çȸÀû ¼ö¿ëÀÇ È®´ë, ºÒÀÓÄ¡·á¼ºñ½º¿¡ ´ëÇÑ Á¢±Ù Áõ°¡¿¡ ÀÇÇØ ÀÌ ¾÷°è´Â »ç¶÷µéÀÇ ÀÚº¸ÀÇ ²ÞÀÇ ½ÇÇöÀ» Áö¿øÇϴµ¥ ÀÖ¾î¼ º¸´Ù Å« ¿ªÇÒÀ» ¿Ï¼öÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù. ºÒÀÓ Ä¡·á°¡ °è¼Ó ÁøÈµÇ°í °³¼±µÊ¿¡ µû¶ó ´õ¿í Á¾ÇÕÀûÀ̰í È¿°úÀûÀÎ °³Àο¡ ¸Â´Â Ä¡·á°¡ Á¦°øµÇ¸ç ¼¼°èÀÇ »ý½Ä ÀÇ·á ¹× °¡Á· °èȹ »óȲ¿¡ Çõ¸íÀ» °¡Á®¿Ã °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÁÖ¸ñ 44»ç)
- Abbott Laboratories
- AbbVie, Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- CooperSurgical, Inc.
- Cryos International ApS
- Eli Lilly and Company
- EMD Serono, Inc.
- Ferring Pharmaceuticals, Inc.
- INVO Bioscience
- Irvine Scientific
- Ivftech Aps
- Medical Electronic Systems, LLC.
- Merck KGaA
- Novartis AG
- Pantec Biosolutions AG
- Pfizer, Inc.
- Sanofi SA
- VIVUS, Inc.
- Xytex Corporation
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå °³¿ä
- ÁÖ¿ä ±â¾÷
- ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
- ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ºÐ¼®
- ¹Ì±¹
- ij³ª´Ù
- ÀϺ»
- Áß±¹
- À¯·´
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ¿µ±¹
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- È£ÁÖ
- Àεµ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¾Æ¸£ÇîÆ¼³ª
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- À̶õ
- À̽º¶ó¿¤
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
Á¦4Àå °æÀï
BJH
Global Fertility Services Market to Reach US$124.2 Billion by 2030
The global market for Fertility Services estimated at US$47.0 Billion in the year 2023, is expected to reach US$124.2 Billion by 2030, growing at a CAGR of 14.9% over the analysis period 2023-2030. Fresh Non-Donor Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of the analysis period. Growth in the Frozen Non-Donor Services segment is estimated at 13.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$12.1 Billion While China is Forecast to Grow at 19.3% CAGR
The Fertility Services market in the U.S. is estimated at US$12.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$31.7 Billion by the year 2030 trailing a CAGR of 19.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.2% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.4% CAGR.
Global Fertility Services Market - Key Trends and Drivers Summarized
How Are Fertility Services Revolutionizing Reproductive Health and Family Planning?
Fertility services are transforming reproductive health and family planning by offering advanced medical interventions and personalized care to individuals and couples facing challenges in conceiving. With increasing awareness and acceptance of fertility treatments, advancements in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), egg freezing, and genetic screening, are giving hope to millions of people worldwide. Fertility services include a range of treatments that help diagnose and treat infertility, support family planning, and improve reproductive health. These services are becoming essential in the modern landscape of healthcare, allowing individuals and couples to realize their dreams of parenthood despite age, medical conditions, or other factors.
In recent years, the demand for fertility services has grown due to societal changes, such as delayed childbearing, lifestyle factors, and rising infertility rates. Fertility clinics now offer a wide array of services, from fertility assessments and hormonal treatments to cutting-edge ART procedures. The rise of egg freezing, particularly among women who wish to preserve their fertility for future pregnancies, has become a significant trend. This expansion of fertility services is not only empowering individuals to take control of their reproductive health but is also making family planning more accessible and inclusive, especially for same-sex couples, single parents, and those facing reproductive health challenges. As fertility treatments advance and societal acceptance grows, these services are playing a transformative role in how people plan their families.
Why Are Fertility Services Critical for Addressing Reproductive Challenges and Expanding Family Planning Options?
Fertility services are critical for addressing reproductive challenges and expanding family planning options because they offer medical solutions to individuals and couples who may face obstacles in conceiving naturally. With the increasing prevalence of infertility—affecting around 10-15% of couples globally—fertility services provide hope and support by diagnosing and treating underlying conditions that hinder conception. Whether due to age, hormonal imbalances, genetic factors, or lifestyle issues, infertility can be emotionally and physically taxing. Fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and egg or sperm donation enable people to overcome these barriers and achieve successful pregnancies.
Fertility services are also crucial in providing options for those who may not face infertility but are seeking alternatives for family planning. Women who choose to delay childbearing for personal or career reasons can now turn to egg freezing, which preserves their eggs at an optimal time, giving them the flexibility to conceive later in life. Additionally, fertility services offer crucial options for LGBTQ+ individuals and couples, as well as single parents, who may require donor eggs, sperm, or surrogacy to start a family. These services ensure that parenthood is not limited by biological constraints or traditional family structures, offering more inclusive and diverse pathways to having children.
Another key role of fertility services is in addressing medical conditions like polycystic ovary syndrome (PCOS), endometriosis, and male infertility issues such as low sperm count or motility. These conditions often go undiagnosed and untreated, but fertility clinics provide targeted treatments and interventions that increase the chances of conception. Furthermore, advancements in genetic screening and preimplantation genetic testing (PGT) allow for the identification of genetic disorders before pregnancy, ensuring healthier outcomes for both parents and babies. This comprehensive approach to fertility care is helping more people navigate complex reproductive challenges and expand their family-building options in ways that were not possible before.
What Are the Expanding Applications and Innovations in Fertility Services Across Reproductive Health?
The applications and innovations in fertility services are rapidly expanding, driven by breakthroughs in medical technology, genetics, and personalized reproductive care. One of the most significant advancements in fertility services is the rise of in vitro fertilization (IVF), which has revolutionized how couples and individuals approach infertility. IVF involves the fertilization of an egg outside the body, followed by the implantation of the embryo into the uterus. As technology improves, success rates for IVF have increased, making it one of the most effective treatments for infertility. Innovations such as time-lapse imaging and embryo monitoring systems allow embryologists to assess the development of embryos with greater precision, improving the chances of successful implantation and pregnancy.
Egg and sperm freezing technologies have also seen significant improvements, providing more opportunities for fertility preservation. Cryopreservation methods, including vitrification, have made it possible to freeze eggs and sperm with higher survival rates, offering individuals the flexibility to delay parenthood. This is particularly important for cancer patients who may face fertility loss due to chemotherapy, as well as women who want to preserve their fertility for personal or professional reasons. Additionally, advancements in sperm extraction techniques have provided solutions for men with low sperm counts or other fertility issues, allowing them to conceive through assisted reproductive technologies.
Another groundbreaking innovation in fertility services is preimplantation genetic testing (PGT), which allows for the genetic screening of embryos before implantation. PGT can detect chromosomal abnormalities or genetic disorders such as cystic fibrosis, sickle cell anemia, and Huntington’s disease, ensuring that only healthy embryos are transferred during IVF. This technology not only increases the chances of a successful pregnancy but also reduces the risk of miscarriage and genetic diseases in the child. Genetic counseling is now an integral part of fertility services, allowing couples to make informed decisions about their reproductive options based on their genetic makeup.
In addition to these technological advancements, fertility services are expanding to include a more holistic approach to reproductive health. Clinics are increasingly offering support services such as fertility coaching, nutritional guidance, mental health counseling, and acupuncture, recognizing the importance of addressing the emotional, physical, and psychological aspects of fertility treatment. Fertility clinics are also embracing digital health tools, with telemedicine consultations, fertility tracking apps, and remote monitoring becoming more common. This shift toward patient-centered care is helping individuals navigate the complex fertility journey with greater support and convenience.
Another area of innovation in fertility services is the growing use of artificial intelligence (AI) and machine learning in fertility treatments. AI-powered systems are being used to analyze large datasets of patient information, embryo development, and treatment outcomes, helping doctors make more accurate decisions about fertility treatment plans. For example, AI can be used to predict the success rates of IVF cycles based on patient history, genetics, and embryo quality, allowing for more personalized and effective treatment strategies. These innovations are making fertility treatments more efficient, accessible, and successful, opening up new possibilities for individuals and couples seeking to build families.
What Factors Are Driving the Growth of the Fertility Services Market?
Several key factors are driving the growth of the fertility services market, including the rising prevalence of infertility, delayed childbearing, advancements in reproductive technologies, and increasing societal acceptance of fertility treatments. One of the primary drivers is the growing global incidence of infertility, which is affecting both men and women. Factors such as lifestyle changes, environmental pollutants, stress, and medical conditions like obesity and polycystic ovary syndrome (PCOS) are contributing to rising infertility rates. As more people face challenges in conceiving naturally, the demand for fertility services continues to rise, with treatments like IVF, IUI, and fertility preservation becoming more commonplace.
Another significant factor contributing to the growth of the fertility services market is the trend toward delayed childbearing. With more women prioritizing their careers, education, and personal goals, many are choosing to have children later in life. However, age is a critical factor in fertility, particularly for women, as fertility declines with age. Fertility services, including egg freezing and IVF, provide solutions for women who wish to preserve their fertility and conceive later in life, leading to increased demand for these services. Additionally, with the rise in second marriages and blended families, fertility services are being used by older individuals or couples who wish to have children together, further driving market growth.
Advancements in reproductive technologies are also playing a crucial role in the expansion of the fertility services market. Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and cryopreservation techniques have improved the success rates of fertility treatments, making them more appealing to individuals and couples seeking reproductive assistance. The integration of AI and machine learning in fertility clinics is further enhancing treatment outcomes by providing more personalized care and optimizing treatment strategies. These technological advancements are making fertility treatments more effective and accessible, encouraging more people to explore fertility options.
The growing societal acceptance of fertility treatments is another major factor driving market growth. Fertility treatments, once considered taboo or stigmatized, are now widely accepted and embraced, especially in developed countries. Public figures and celebrities openly discussing their fertility journeys have helped to reduce the stigma around infertility, encouraging more people to seek fertility services. Moreover, legal and social advancements, such as the recognition of same-sex marriages and the availability of surrogacy and donor programs, are providing new pathways for LGBTQ+ individuals and single parents to build families. As these treatments become more accessible and normalized, the fertility services market continues to expand.
Increasing government support and healthcare coverage for fertility treatments are also driving the growth of the market. In many countries, insurance companies and healthcare systems are beginning to cover a portion of the costs associated with fertility treatments like IVF, making them more affordable for a broader population. Government initiatives that promote reproductive health and provide financial assistance for fertility treatments are also helping to increase access to these services. In regions where fertility rates are declining, governments are investing in fertility treatments as part of national efforts to boost population growth, further contributing to the expansion of the market.
In conclusion, the fertility services market is poised for significant growth as more individuals and couples seek reproductive assistance to overcome infertility, delay parenthood, or pursue non-traditional family-building options. With advancements in reproductive technologies, growing societal acceptance, and increasing access to fertility services, the industry is set to play an even larger role in helping people realize their dreams of parenthood. As fertility treatments continue to evolve and improve, they will provide more inclusive, effective, and personalized care, revolutionizing the landscape of reproductive health and family planning worldwide.
Select Competitors (Total 44 Featured) -
- Abbott Laboratories
- AbbVie, Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- CooperSurgical, Inc.
- Cryos International ApS
- Eli Lilly and Company
- EMD Serono, Inc.
- Ferring Pharmaceuticals, Inc.
- INVO Bioscience
- Irvine Scientific
- Ivftech Aps
- Medical Electronic Systems, LLC.
- Merck KGaA
- Novartis AG
- Pantec Biosolutions AG
- Pfizer, Inc.
- Sanofi SA
- VIVUS, Inc.
- Xytex Corporation
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Fertility Services - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Increasing Global Infertility Rates Driving Demand for Fertility Services
- Advancements in Assisted Reproductive Technologies (ART) Enhancing Success Rates
- Growing Acceptance and Legalization of IVF and Surrogacy Across Different Regions
- Market Trends Toward Personalized Treatment Plans Based on Genetic Testing
- Future Directions: Integration of AI and Machine Learning in Fertility Treatment Protocols
- Technological Innovations in Embryo Screening and Preservation Techniques
- Global Increase in Same-Sex Couples and Single Parents Using Fertility Services
- Regulatory and Ethical Considerations in Egg and Sperm Donation
- Development of Mobile Apps and Online Platforms for Fertility Consultation and Management
- Market Response to Growing Trends in Egg Freezing for Career Planning
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Fertility Services Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Egg & Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 30: World Historic Review for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: World 16-Year Perspective for Clinical Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 32: USA Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: USA 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: USA 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- CANADA
- TABLE 38: Canada Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 39: Canada Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: Canada 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 41: Canada Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: Canada 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- JAPAN
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 44: Japan Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: Japan Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: Japan 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 47: Japan Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: Japan Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: Japan 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- CHINA
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 50: China Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: China Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: China 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 53: China Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 54: China Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: China 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- EUROPE
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 56: Europe Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 57: Europe Historic Review for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: Europe 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 59: Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: Europe 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 62: Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: Europe 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- FRANCE
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 65: France Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: France Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: France 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 68: France Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: France Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: France 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- GERMANY
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 71: Germany Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: Germany Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Germany 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 74: Germany Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Germany Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Germany 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- ITALY
- TABLE 77: Italy Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: Italy Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: Italy 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 80: Italy Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Italy Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: Italy 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- UNITED KINGDOM
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 83: UK Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: UK Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: UK 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 86: UK Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: UK Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: UK 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- SPAIN
- TABLE 89: Spain Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: Spain Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Spain 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 92: Spain Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: Spain Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: Spain 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- RUSSIA
- TABLE 95: Russia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 96: Russia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: Russia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 98: Russia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: Russia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Russia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- REST OF EUROPE
- TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Rest of Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Rest of Europe 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: Rest of Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: Rest of Europe 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- ASIA-PACIFIC
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 108: Asia-Pacific Historic Review for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: Asia-Pacific 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: Asia-Pacific 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 114: Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 115: Asia-Pacific 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- AUSTRALIA
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 116: Australia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 117: Australia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 118: Australia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 119: Australia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 120: Australia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 121: Australia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- INDIA
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 122: India Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 123: India Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 124: India 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 125: India Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 126: India Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 127: India 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- SOUTH KOREA
- TABLE 128: South Korea Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 129: South Korea Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 130: South Korea 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 131: South Korea Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 132: South Korea Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 133: South Korea 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- REST OF ASIA-PACIFIC
- TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 135: Rest of Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 138: Rest of Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- LATIN AMERICA
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 140: Latin America Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 141: Latin America Historic Review for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 142: Latin America 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 143: Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 144: Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 145: Latin America 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 146: Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 147: Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 148: Latin America 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- ARGENTINA
- TABLE 149: Argentina Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 150: Argentina Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 151: Argentina 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 152: Argentina Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 153: Argentina Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 154: Argentina 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- BRAZIL
- TABLE 155: Brazil Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 156: Brazil Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 157: Brazil 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 158: Brazil Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 159: Brazil Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 160: Brazil 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- MEXICO
- TABLE 161: Mexico Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 162: Mexico Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 163: Mexico 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 164: Mexico Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 165: Mexico Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 166: Mexico 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- REST OF LATIN AMERICA
- TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 168: Rest of Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 169: Rest of Latin America 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 171: Rest of Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 172: Rest of Latin America 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- MIDDLE EAST
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 173: Middle East Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 174: Middle East Historic Review for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 175: Middle East 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 176: Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 177: Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 178: Middle East 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 179: Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 180: Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 181: Middle East 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- IRAN
- TABLE 182: Iran Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 183: Iran Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 184: Iran 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 185: Iran Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 186: Iran Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 187: Iran 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- ISRAEL
- TABLE 188: Israel Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 189: Israel Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 190: Israel 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 191: Israel Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 192: Israel Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 193: Israel 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- SAUDI ARABIA
- TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 195: Saudi Arabia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 196: Saudi Arabia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 198: Saudi Arabia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 199: Saudi Arabia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- UNITED ARAB EMIRATES
- TABLE 200: UAE Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 201: UAE Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 202: UAE 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 203: UAE Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 204: UAE Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 205: UAE 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- REST OF MIDDLE EAST
- TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 207: Rest of Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 208: Rest of Middle East 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 210: Rest of Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 211: Rest of Middle East 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
- AFRICA
- Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 212: Africa Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 213: Africa Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 214: Africa 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
- TABLE 215: Africa Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 216: Africa Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 217: Africa 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
IV. COMPETITION